+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Esomeprazole Market by Product Type (Branded, Generic), Formulation (Capsules, Oral Suspension, Tablets), Route of Administration, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Esomeprazole Market by Product Type (Branded, Generic), Formulation (Capsules, Oral Suspension, Tablets), Route of Administration, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Sale

Esomeprazole Market by Product Type (Branded, Generic), Formulation (Capsules, Oral Suspension, Tablets), Route of Administration, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015377
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The esomeprazole market continues to evolve, shaped by shifting therapeutic standards, regulatory changes, and new digital health initiatives. Senior stakeholders navigating this environment must consider clinical advances, patient outcomes, and operational challenges to secure growth and competitive advantage.

Market Snapshot: Esomeprazole Market Overview

The Esomeprazole Market grew from USD 1.83 billion in 2024 to USD 1.94 billion in 2025. It is expected to continue growing at a CAGR of 5.99%, reaching USD 2.59 billion by 2030.

Scope & Segmentation

  • Product Types: Branded, including both authorized generics and original products, alongside a diverse range of generic alternatives.
  • Formulations: Capsules, oral suspensions, and tablets to meet diverse dosing needs.
  • Routes of Administration: Intravenous and oral applications allow coverage for acute hospital requirements and long-term outpatient management.
  • Distribution Channels: Hospital pharmacies, online pharmacies (via mobile apps and web platforms), and retail pharmacies enable efficient patient reach and consultation.
  • Applications: Management and prevention for conditions such as erosive esophagitis, gastroesophageal reflux disease, and NSAID-induced ulcers.
  • Geographies: Coverage includes the Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key countries across Western, Central, Northern, and Middle Eastern regions), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Analysis comprises AstraZeneca PLC, Teva Pharmaceutical Industries Limited, Sandoz International GmbH, Dr. Reddy's Laboratories Limited, Sun Pharmaceutical Industries Limited, Viatris Inc, Lupin Limited, Aurobindo Pharma Limited, Cipla Limited, and Zydus Lifesciences Limited.

Key Takeaways for Senior Decision-Makers

  • Market growth is propelled by advances in tailored formulations and new delivery systems that support both acute and maintenance dosing scenarios.
  • Increasing healthcare digitization, such as telemedicine and pharmacy platforms, fosters enhanced patient adherence and streamlined supply logistics.
  • Regulatory changes are expediting patient access through adaptive product licensing, reflecting an industry-wide shift towards real-world evidence in approvals.
  • Demand for esomeprazole is influenced by varying therapeutic needs, population demographics, and reimbursement policies across major regional markets.
  • Company strategies reveal intensified focus on innovation, co-development, and optimized supply chain resilience, especially in response to evolving pricing and trade factors.

Impact of United States Tariffs (2025)

Forthcoming tariffs in the United States are expected to affect esomeprazole supply chains by increasing input costs and reshaping import strategies. Manufacturers are evaluating domestic sourcing and renegotiating supplier contracts to mitigate disruptions. Downstream, cost adjustments may influence pricing models for pharmacies and patient affordability. Distributors are preemptively expanding supplier networks in response to potential volatility, while regulators may tighten compliance oversight due to shifts in parallel trade and gray market activity.

Methodology & Data Sources

This research applies a comprehensive methodology, aggregating peer-reviewed clinical literature, regulatory documents, and primary interviews with industry leaders and supply chain executives. Multivariate analyses and scenario modeling ensure that findings reflect current and emerging trends impacting the esomeprazole market.

Why This Report Matters for Senior Leadership

  • Provides actionable intelligence for aligning business strategy with advancements in esomeprazole therapy, regulatory adaptation, and channel innovation.
  • Delivers multi-dimensional segmentation, equipping executive teams to identify high-value product, geographic, and distribution opportunities ahead of market movements.
  • Clarifies the impact of U.S. tariffs and other macroeconomic factors, empowering proactive supply chain and pricing decisions for sustained market stability.

Conclusion

As the esomeprazole market adapts to clinical, regulatory, and commercial evolution, senior decision-makers can leverage these research insights to refine strategy and ensure resilient growth. Focused execution across innovation, partnerships, and supply chain management will distinguish market leaders in a dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in OTC esomeprazole sales in European markets driven by self-care trends and GI symptom awareness
5.2. Introduction of esomeprazole nanoencapsulation formulations targeting improved bioavailability in geriatric patients
5.3. Heightened market competition following expiration of esomeprazole patents and influx of generic counterparts
5.4. Rapid adoption of bundled esomeprazole and clarithromycin kits for streamlined H pylori eradication protocols
5.5. Rise of digital prescription platforms boosting esomeprazole adherence monitoring and telehealth GI consult integration
5.6. Expansion of pediatric-friendly esomeprazole granule sachets addressing infant reflux management in Asia Pacific
5.7. Impact of long-term PPI safety concerns on demand for low-dose esomeprazole maintenance therapies
5.8. Pricing pressures from biosimilar esomeprazole magnesium entrants reshaping hospital formulary negotiations
5.9. Sustainability demands prompting eco-friendly manufacturing of esomeprazole delayed-release tablets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Esomeprazole Market, by Product Type
8.1. Introduction
8.2. Branded
8.2.1. Authorized Generic
8.2.2. Original Product
8.3. Generic
9. Esomeprazole Market, by Formulation
9.1. Introduction
9.2. Capsules
9.3. Oral Suspension
9.4. Tablets
10. Esomeprazole Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Esomeprazole Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.3.1. Mobile App
11.3.2. Web Platform
11.4. Retail Pharmacy
12. Esomeprazole Market, by Application
12.1. Introduction
12.2. Erosive Esophagitis
12.3. Gastroesophageal Reflux Disease
12.4. Nsaid-Induced Ulcer Prevention
13. Americas Esomeprazole Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Esomeprazole Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Esomeprazole Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AstraZeneca PLC
16.3.2. Teva Pharmaceutical Industries Limited
16.3.3. Sandoz International GmbH
16.3.4. Dr. Reddy's Laboratories Limited
16.3.5. Sun Pharmaceutical Industries Limited
16.3.6. Viatris Inc
16.3.7. Lupin Limited
16.3.8. Aurobindo Pharma Limited
16.3.9. Cipla Limited
16.3.10. Zydus Lifesciences Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ESOMEPRAZOLE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ESOMEPRAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ESOMEPRAZOLE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ESOMEPRAZOLE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ESOMEPRAZOLE MARKET: RESEARCHAI
FIGURE 26. ESOMEPRAZOLE MARKET: RESEARCHSTATISTICS
FIGURE 27. ESOMEPRAZOLE MARKET: RESEARCHCONTACTS
FIGURE 28. ESOMEPRAZOLE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ESOMEPRAZOLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ESOMEPRAZOLE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ESOMEPRAZOLE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY AUTHORIZED GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY AUTHORIZED GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORIGINAL PRODUCT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORIGINAL PRODUCT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY MOBILE APP, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY WEB PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY WEB PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY EROSIVE ESOPHAGITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY EROSIVE ESOPHAGITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY NSAID-INDUCED ULCER PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY NSAID-INDUCED ULCER PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 92. CANADA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 93. CANADA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. CANADA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 100. CANADA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 101. CANADA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 178. GERMANY ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 179. GERMANY ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 180. GERMANY ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 192. FRANCE ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 193. FRANCE ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 194. FRANCE ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. ITALY ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. ITALY ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 220. ITALY ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 221. ITALY ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 222. ITALY ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. ITALY ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. ITALY ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ITALY ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ITALY ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. ITALY ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. ITALY ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. ITALY ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 234. SPAIN ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 235. SPAIN ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 236. SPAIN ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 290. DENMARK ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 291. DENMARK ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. DENMARK ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. DENMARK ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. DENMARK ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. DENMARK ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. DENMARK ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. DENMARK ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. DENMARK ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. QATAR ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. QATAR ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. QATAR ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 318. QATAR ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 319. QATAR ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 320. QATAR ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 321. QATAR ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. QATAR ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. QATAR ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. QATAR ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. QATAR ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. QATAR ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. QATAR ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. QATAR ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. FINLAND ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. FINLAND ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. FINLAND ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 332. FINLAND ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 333. FINLAND ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 334. FINLAND ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 335. FINLAND ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 336. FINLAND ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 337. FINLAND ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. FINLAND ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. FINLAND ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 340. FINLAND ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 341. FINLAND ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. FINLAND ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 351. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 354. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 355. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 356. SWEDEN ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 357. NIGERIA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 358. NIGERIA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 359. NIGERIA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 360. NIGERIA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 361. NIGERIA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 362. NIGERIA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 363. NIGERIA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Esomeprazole market report include:
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Limited
  • Sandoz International GmbH
  • Dr. Reddy's Laboratories Limited
  • Sun Pharmaceutical Industries Limited
  • Viatris Inc
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.59 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Esomeprazole Capsule Market by Application (Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Zollinger-Ellison Syndrome), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, End User - Global Forecast 2025-2030 - Product Image

Esomeprazole Capsule Market by Application (Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Zollinger-Ellison Syndrome), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Esomeprazole Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Esomeprazole Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Esomeprazole Magnesium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Esomeprazole Magnesium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Esomeprazole (CAS 119141-88-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Esomeprazole (CAS 119141-88-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Proton Pump Inhibitors Market Report 2025 - Product Image

Proton Pump Inhibitors Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Esomeprazole Market

Esomeprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. It works by reducing the amount of acid produced in the stomach, which helps to relieve symptoms such as heartburn, difficulty swallowing, and persistent cough. Esomeprazole is available in both prescription and over-the-counter forms. Esomeprazole is one of the most commonly prescribed PPIs, and is widely used in the treatment of GERD and other gastrointestinal disorders. It is generally well tolerated, with few side effects. It is also available in combination with other medications, such as antibiotics, to treat more severe cases of GERD. Some companies that produce esomeprazole include AstraZeneca, Pfizer, Teva Pharmaceuticals, and Mylan. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.